¼¼°èÀÇ ÇコÄÉ¾î ºí¸®½ºÅÍ Æ÷Àå ½ÃÀå
Healthcare Blister Packaging
»óǰÄÚµå : 1774895
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 474 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,239,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,719,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

ÇコÄÉ¾î ºí¸®½ºÅÍ Æ÷Àå ¼¼°è ½ÃÀåÀº 2030³â±îÁö 286¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 203¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ÇコÄÉ¾î ºí¸®½ºÅÍ Æ÷Àå ¼¼°è ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö CAGR 5.9%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 286¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ Ä«µå À¯ÇüÀº CAGR 4.6%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 160¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Ŭ·¥½© À¯Çü ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 7.8%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 55¾ï ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 9.1%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ÇコÄÉ¾î ºí¸®½ºÅÍ Æ÷Àå ½ÃÀåÀº 2024³â¿¡ 55¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 57¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 9.1%¸¦ ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 3.0%¿Í 5.8%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 3.8%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ÇコÄÉ¾î ºí¸®½ºÅÍ Æ÷Àå ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

ºí¸®½ºÅÍ Æ÷ÀåÀÌ ÇコÄÉ¾î Æ÷ÀåÀÇ Ç¥ÁØÀÌ µÇ°í ÀÖ´Â ÀÌÀ¯´Â ¹«¾ùÀϱî?

ÇコÄÉ¾î ºí¸®½ºÅÍ Æ÷Àå ½ÃÀåÀº Á¦¾à ¹× ÀÇ·á »ê¾÷ÀÇ ÁøÈ­ÇÏ´Â ¼ö¿ä¿¡ ÈûÀÔ¾î ºü¸£°Ô º¯È­Çϰí ÀÖ½À´Ï´Ù. ³Î¸® »ç¿ëµÇ´Â º¸È£ Æ÷Àå ¼Ö·ç¼ÇÀÎ ºí¸®½ºÅÍ Æ÷ÀåÀº Á¦Ç°ÀÇ ¹«°á¼ºÀ» º¸ÀåÇϰí, ȯÀÚÀÇ ÄÄÇöóÀ̾𽺸¦ Çâ»ó½Ã۸ç, ¾ö°ÝÇÑ ±ÔÁ¦ ±âÁØÀ» ÃæÁ·½Ãų ¼ö Àֱ⠶§¹®¿¡ ¼±È£µÇ´Â Æ÷Àå ¼Ö·ç¼ÇÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¯È­ÀÇ ¹è°æ¿¡´Â Àü ¼¼°è ÀǾàǰ ¼ö¿ä Áõ°¡, ´õ ¸¹Àº ÀǾàǰÀ» ÇÊ¿ä·Î ÇÏ´Â °í·ÉÈ­, º¯Á¶ ¹æÁö ¹× ¼Ò¾Æ ³»¼º Æ÷Àå ¼Ö·ç¼ÇÀÇ Çʿ伺ÀÌ ÀÖ½À´Ï´Ù. ƯÈ÷ Á¦¾à ºÐ¾ß¿¡¼­ ºí¸®½ºÅÍ Æ÷ÀåÀ» äÅÃÇÏ´Â ÀÌÀ¯´Â ÀǾàǰÀÇ È¿´ÉÀ» ¼Õ»ó½Ãų ¼ö ÀÖ´Â ½À±â, »ê¼Ò, ºû°ú °°Àº ȯ°æÀû ¿äÀο¡ ´ëÇÑ Å¹¿ùÇÑ º¸È£ ±â´ÉÀ» Á¦°øÇϱ⠶§¹®ÀÔ´Ï´Ù. ¶ÇÇÑ, 1ȸºÐ Æ÷ÀåÀ¸·Î Á¤È®ÇÑ º¹¿ë·®À» º¸ÀåÇÏ°í ¿À¿°À» ¹æÁöÇÏ¿© ¼ÒºñÀÚÀÇ ¾ÈÀüÀ» °­È­ÇÕ´Ï´Ù. ¶ÇÇÑ, QRÄÚµå, ±Ù°Å¸® ¹«¼±Åë½Å(NFC) ÅÂ±×¿Í °°Àº ½º¸¶Æ® ±â´ÉÀ» ÅëÇÕÇÒ ¼ö ÀÖ°Ô µÊ¿¡ µû¶ó ȯÀÚ°¡ ÀǾàǰ Á¤º¸¿¡ Á¢±ÙÇÒ ¼ö ÀÖ´Â ¹æ¹ýÀÌ Çõ½ÅÀûÀ¸·Î °³¼±µÇ¾î ó¹æµÈ Ä¡·áÀÇ ¼øÀÀµµ¸¦ ³ôÀÏ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. Áö¼Ó°¡´É¼ºµµ Áß¿äÇÑ ¿øµ¿·ÂÀÌ µÇ°í ÀÖÀ¸¸ç, ȯ°æ¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó Á¦Á¶¾÷üµéÀº ÀçȰ¿ëÀÌ °¡´ÉÇÑ ¼ÒÀç¿Í »ýºÐÇØ¼º ¼ÒÀ縦 Á¡Á¡ ´õ ¸¹ÀÌ »ç¿ëÇϰí ÀÖ½À´Ï´Ù. FDA¿Í À¯·´ÀǾàǰû(EMA)°ú °°Àº ±ÔÁ¦ ±â°üÀº ±âÁ¸ º´À̳ª ¹ÙÀ̾˺¸´Ù ºí¸®½ºÅÍ Æ÷ÀåÀ» ¼±È£ÇÏ´Â ¾ö°ÝÇÑ °¡À̵å¶óÀÎÀ» Àǹ«È­ÇÏ¿© ºí¸®½ºÅÍ Æ÷ÀåÀÇ Ã¤ÅÃÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Á¦Á¶, º¸°ü, ¿î¼Û Ãø¸é¿¡¼­ ºí¸®½ºÅÍ Æ÷ÀåÀÇ ºñ¿ë È¿À²¼ºÀÌ ³ô´Ù´Â Á¡µµ ½ÃÀå¿¡¼­ ¿ìÀ§¸¦ Á¡Çϰí ÀÖ½À´Ï´Ù. ÀϹÝÀǾàǰ(OTC) ¹× °Ç°­±â´É½Äǰ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í ¼¿ÇÁ¸ÞµðÄÉÀÌ¼Ç Æ®·»µåÀÇ ±Þ°ÝÇÑ È®´ëµµ ½ÃÀåÀÇ Àúº¯À» ³ÐÈ÷°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀÌ º¹ÇÕÀûÀ¸·Î ÀÛ¿ëÇÏ¿© ºí¸®½ºÅÍ Æ÷ÀåÀº ÀǾàǰ Æ÷ÀåÀÇ °áÁ¤ÀûÀÎ ¼Ö·ç¼ÇÀ¸·Î ºÎ»óÇϰí ÀÖÀ¸¸ç, ŸÀÇ ÃßÁ¾À» ºÒÇãÇÏ´Â º¸È£¼º, »ç¿ë ÆíÀǼº ¹× ±ÔÁ¦ Áؼö¸¦ Á¦°øÇÕ´Ï´Ù.

½º¸¶Æ®Çϰí Áö¼Ó°¡´ÉÇÑ ºí¸®½ºÅÍ Æ÷ÀåÀÇ ºÎ»óÀ» ÃËÁøÇÏ´Â ¿äÀÎÀº ¹«¾ùÀϱî?

ºí¸®½ºÅÍ Æ÷ÀåÀÇ ±â¼ú ¹ßÀüÀº Áö¼Ó°¡´É¼º, ÆíÀǼº, ȯÀÚ Âü¿©µµ¸¦ ³ôÀ̱â À§ÇÑ Çõ½ÅÀ¸·Î ÀÎÇØ ºí¸®½ºÅÍ Æ÷Àå »ê¾÷À» Å©°Ô º¯È­½ÃÄÑ ¿Ô½À´Ï´Ù. RFID, NFC, ºí·çÅõ½º Áö¿ø ±â´É°ú °°Àº µðÁöÅÐ ¼Ö·ç¼ÇÀ» ÅëÇÕÇÑ ½º¸¶Æ® Æ÷ÀåÀº ÀǾàǰÀÇ °ü¸®, ÃßÀû ¹× ¼Òºñ ¹æ½ÄÀ» º¯È­½Ã۰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀº º¹¾à ¼øÀÀµµ¸¦ ¸ð´ÏÅ͸µÇÏ´Â µ¥ µµ¿òÀÌ µÇ¸ç, ÀÇ·á ¼­ºñ½º Á¦°øÀڴ ȯÀÚ°¡ ó¹æµÈ ¾à¹°À» Á¦´ë·Î º¹¿ëÇϰí ÀÖ´ÂÁö ¿©ºÎ¸¦ ÃßÀûÇÒ ¼ö ÀÖ½À´Ï´Ù. À̴ ƯÈ÷ ¾ö°ÝÇÑ Åõ¾à ½ºÄÉÁÙÀÌ ÇÊ¿äÇÑ ¸¸¼ºÁúȯ °ü¸®¿¡ µµ¿òÀÌ µË´Ï´Ù. ¶ÇÇÑ, ÇÃ¶ó½ºÆ½ Æó±â¹° ¹× ź¼Ò¹ßÀÚ±¹ °¨¼Ò°¡ ½Ã±ÞÇÑ »óȲ¿¡¼­ Áö¼Ó°¡´ÉÇÑ ºí¸®½ºÅÍ Æ÷ÀåÀÌ Àα⸦ ²ø°í ÀÖ½À´Ï´Ù. °¢ ¾÷üµéÀº ±âÁ¸ ¼ÒÀç¿Í µ¿ÀÏÇÑ ¼öÁØÀÇ º¸È£ ±â´ÉÀ» °¡Áö°í ÀÖÀ¸¸é¼­µµ ȯ°æ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» ÃÖ¼ÒÈ­ÇÑ ÀçȰ¿ë °¡´ÉÇÑ Á¾ÀÌ º£À̽º, ¹ÙÀÌ¿À ±â¹Ý Æú¸®¸ÓÀÇ Ã¤¿ëÀ» ´Ã¸®°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Á¦Ç°ÀÇ ¾ÈÀü¼ºÀ» À¯ÁöÇϸ鼭 Àç·á »ç¿ë·®À» ÃÖ¼ÒÈ­Çϴ ÷´Ü ¹è¸®¾î Çʸ§µµ ³Î¸® äÅõǰí ÀÖ½À´Ï´Ù. Áö¼Ó°¡´É¼º ÃßÁøÀº ±ÔÁ¦ ÁÖµµÇüÀÏ »Ó¸¸ ¾Æ´Ï¶ó ¼ÒºñÀÚ ÁÖµµÇüÀ̸ç, ÃÖÁ¾ ¼ÒºñÀÚ´Â ÇöÀç ÇコÄɾ Æ÷ÇÔÇÑ ¸ðµç »ê¾÷¿¡¼­ ȯ°æ ģȭÀûÀÎ ¼Ö·ç¼ÇÀ» ¿ä±¸Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °í¼Ó ¹× Á¤¹Ðµµ¸¦ ÁöÇâÇÏ´Â ºí¸®½ºÅÍ Æ÷Àå±âÀÇ ²÷ÀÓ¾ø´Â ±â¼ú Çõ½ÅÀº »ý»ê È¿À²À» ³ôÀ̰í, ÀǾàǰ Á¦Á¶¾÷üÀÇ È®À强À» Çâ»ó½ÃŰ¸é¼­ ºñ¿ëÀ» Àý°¨Çϰí ÀÖ½À´Ï´Ù. ºí¸®½ºÅÍ Æ÷Àå¿¡ ·¹´õ Á¶°¢°ú µðÁöÅÐ Àμ⸦ µµÀÔÇÏ¿© ºê·£µù °­È­, À§Á¶ ¹æÁö, ȯÀÚ ¸ÂÃãÇü Ä¿¹Â´ÏÄÉÀ̼ÇÀÌ °¡´ÉÇØÁ³½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú °³¹ß·Î ºí¸®½ºÅÍ ÆÐŰ¡Àº Áö¼Ó°¡´É¼º°ú ±â´É¼ºÀ» °­È­ÇÑ ¹Ì·¡Çü ÇコÄÉ¾î ÆÐŰ¡À¸·Î ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù. µðÁöÅÐ Çコ Æ®·»µå¿Í ģȯ°æ ÆÐŰ¡ ¼Ö·ç¼ÇÀÇ °áÇÕÀº °æÀï ±¸µµ¸¦ ÀçÁ¤ÀÇÇϰí ÀÖÀ¸¸ç, Á¦Á¶¾÷üµéÀº ºü¸£°Ô ÁøÈ­ÇÏ´Â ½ÃÀå¿¡¼­ ¿ìÀ§¸¦ Á¡Çϱâ À§ÇØ Ã·´Ü ±â¼ú¿¡ ´ëÇÑ ÅõÀÚ¸¦ ¾Æ³¢Áö ¾Ê°í ÀÖ½À´Ï´Ù.

¼ÒºñÀÚ Çൿ°ú ±ÔÁ¦´Â ¾î¶»°Ô ½ÃÀåÀ» Çü¼ºÇϰí Àִ°¡?

¼ÒºñÀÚ ¼±È£µµ¿Í ¾ö°ÝÇÑ ±ÔÁ¦´Â ÇコÄÉ¾î ºí¸®½ºÅÍ Æ÷Àå ½ÃÀå Çü¼º¿¡ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. °¡Àå Áß¿äÇÑ Çൿ º¯È­ Áß Çϳª´Â ƯÈ÷ °í·ÉÈ­ »çȸ¿Í °Ç°­ ÁöÇâÀûÀÎ ¼ÒºñÀÚµé »çÀÌ¿¡¼­ ÀÚ°¡ Ä¡·á¿Í ÀÏ¹Ý ÀǾàǰ¿¡ ´ëÇÑ ÀÇÁ¸µµ°¡ ³ô¾ÆÁö°í ÀÖ´Ù´Â Á¡ÀÔ´Ï´Ù. ºí¸®½ºÅÍ ÆÐŰÁö´Â ¹Ì¸® °è·®µÈ ¿ë·®, º¹¾à ½ºÄÉÁÙÀÇ ¿ëÀ̼º, º¯Á¶ ¹æÁö ±â´É µîÀ» Á¦°øÇÏ¿© ȯÀÚÀÇ ¾ÈÀüÀ» º¸ÀåÇÔÀ¸·Î½á ÀÌ·¯ÇÑ Ãß¼¼¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. COVID-19 »çÅ·ΠÀÎÇØ ¼¿ÇÁ¸ÞµðÄÉÀ̼ǰú ÀüÀÚ ¾àǰ ä³Î·ÎÀÇ ÀüȯÀÌ ´õ¿í °¡¼ÓÈ­µÇ¾ú°í, ¹è¼Û°ú º¸°üÀÌ ¿ëÀÌÇÑ ºí¸®½ºÅÍ Æ÷Àå ÀǾàǰ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ¿´½À´Ï´Ù. ¶ÇÇÑ, ¾î¸°ÀÌ¿Í ³ëÀÎ Àα¸ÀÇ Áõ°¡·Î ÀÎÇØ ¾ÈÀü¼º°ú Á¢±Ù¼ºÀÇ ±ÕÇüÀ» ¸ÂÃá ¾î¸°ÀÌ¿Í ³ëÀΠģȭÀûÀÎ Æ÷Àå¿¡ ´ëÇÑ ´ÏÁî°¡ »ý°Ü³ª°í ÀÖ½À´Ï´Ù. ÀǾàǰ Æ÷Àå¿¡ ´ëÇÑ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©´Â Àü ¼¼°èÀûÀ¸·Î °­È­µÇ°í ÀÖÀ¸¸ç, ÀϷùøÈ£, ÃßÀû¼º, ¼Ò¾Æ ³»¼º ±âÁØÀ» ÁؼöÇØ¾ß ÇÕ´Ï´Ù. ¹Ì±¹ ½ÄǰÀǾ౹(FDA), À¯·´ÀǾàǰû(EMA) ¹× ±âŸ ±ÔÁ¦ ±â°üÀº ÀǾàǰ À§Á¶¸¦ ¾ïÁ¦ÇÏ°í ¼ÒºñÀÚ º¸È£¸¦ º¸ÀåÇϱâ À§ÇØ ºí¸®½ºÅÍ Æ÷ÀåÀÌ ¾ö°ÝÇÑ ¾ÈÀü ¹× À¯Åë ±âÇÑ ¿ä°ÇÀ» ÃæÁ·Çϵµ·Ï ¿ä±¸Çϰí ÀÖ½À´Ï´Ù. À¯·´¿¡¼­´Â À§Á¶ ÀǾàǰ Áöħ(FMD)¿¡ µû¶ó ¸ðµç ó¹æ¾à¿¡ ½Ã¸®¾ó¶óÀÌÁ¦À̼Ç(serialization)ÀÌ Àǹ«È­µÇ¸é¼­ ºí¸®½ºÅÍ ÆÑ ³» ÃßÀû ÃßÀû ±â¼úÀÌ ÅëÇյǰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Á¦¾à ¾÷°è¿¡ ¿¬°£ ¼ö½Ê¾ï ´Þ·¯ÀÇ ÇÇÇØ¸¦ ÀÔÈ÷´Â À§Á¶ ÀǾàǰÀÌ Áõ°¡ÇÔ¿¡ µû¶ó º¯Á¶ ¹æÁö ¹× º¸¾È °­È­¸¦ À§ÇÑ Æ÷Àå¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ±ÔÁ¦°¡ ºü¸£°Ô ÁøÈ­ÇÔ¿¡ µû¶ó Á¦¾àȸ»ç´Â ±ÔÁ¤ Áؼö¸¦ º¸ÀåÇÒ »Ó¸¸ ¾Æ´Ï¶ó ¼ÒºñÀÚÀÇ ½Å·Ú¸¦ ³ôÀÏ ¼ö ÀÖ´Â Çõ½ÅÀûÀÎ ºí¸®½ºÅÍ ÆÐŰ¡ ¼Ö·ç¼ÇÀ» äÅÃÇØ¾ß ÇÕ´Ï´Ù. ±× °á°ú, Àü ¼¼°è ¼ÒºñÀÚÀÇ ±âÈ£ º¯È­¿Í ¾ÈÀü ¿ä±¸»çÇ׿¡ ´ëÀÀÇÏ´Â Áö´ÉÀûÀÌ°í »ç¿ëÇϱ⠽¬¿ì¸ç ÄÄÇöóÀ̾𽺸¦ ÁؼöÇÏ´Â ÆÐŰ¡ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

ÇコÄÉ¾î ºí¸®½ºÅÍ Æ÷Àå ½ÃÀåÀÇ Æø¹ßÀûÀÎ ¼ºÀå ¿øµ¿·ÂÀº ¹«¾ùÀΰ¡?

ÇコÄÉ¾î ºí¸®½ºÅÍ Æ÷Àå ½ÃÀåÀÇ ¼ºÀåÀº ¿©·¯ °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖÀ¸¸ç, °¢ ¿äÀÎÀº ¾÷°èÀÇ ±Ëµµ¿¡ Å« ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ¿äÀÎ Áß Çϳª´Â ÀÇ·áºñ Áõ°¡, ¸¸¼ºÁúȯ Áõ°¡, ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ÈûÀÔ¾î ¼¼°è ÀǾàǰ ºÎ¹®ÀÌ ±Þ¼ºÀåÇϰí ÀÖ´Ù´Â Á¡ÀÔ´Ï´Ù. ¾ÈÀüÇϰí È¿À²ÀûÀÎ ¾à¹°Àü´Þ ½Ã½ºÅÛÀÇ Çʿ伺ÀÌ ´ëµÎµÊ¿¡ µû¶ó, ºí¸®½ºÅÍ ÆÐŰÁö´Â ÁøÈ­ÇÏ´Â ±ÔÁ¦¿¡ µû¶ó ȯÀÚ ¾ÈÀü¼ºÀ» ³ôÀ̰íÀÚ ÇÏ´Â Á¦¾à»çµé¿¡°Ô ¼±È£µÇ´Â ¼±ÅÃÀÌ µÇ°í ÀÖ½À´Ï´Ù. E-Commerce¿Í µðÁöÅÐ ÇコÄÉ¾î ¼Ö·ç¼ÇÀÇ ±ÞÁõÀº ¿î¼Û Áß ¾àǰÀÇ ¹«°á¼ºÀ» º¸ÀåÇÏ´Â º¸È£, °æ·®, º¯Á¶ ¹æÁö Æ÷Àå¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡µµ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Àç·á°úÇÐÀÇ ¹ßÀüÀ¸·Î ±ÔÁ¦Àû ¿ä±¸¿Í ¼ÒºñÀÚ ¼±È£µµ¸¦ ¸ðµÎ ÃæÁ·ÇÏ´Â °í¹è¸®¾î Çʸ§, ģȯ°æ ´ëüǰ, ½º¸¶Æ® Æ÷Àå ¼Ö·ç¼ÇÀÇ °³¹ßÀÌ °¡´ÉÇØÁ³½À´Ï´Ù. º¹¾à ¼øÀÀµµ¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó, ƯÈ÷ °í·ÉÀÚ ¹× ¸¸¼ºÁúȯ ȯÀÚµéÀ» À§ÇÑ Ä¶¸°´õ º£½º¿Í 1ȸ Á¦°ø·® ´ÜÀ§ÀÇ ºí¸®½ºÅÍ Æ÷ÀåÀÇ Ã¤ÅÃÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Á¦Á¶ ¹× Æ÷Àå ¼öʱâ°ü(CMO ¹× CPO)ÀÇ È®´ë·Î ºñ¿ë È¿À²¼º°ú È®À强ÀÌ ¶Ù¾î³­ ºí¸®½ºÅÍ Æ÷Àå ¼Ö·ç¼ÇÀÌ È°¼ºÈ­µÇ¾î Áß¼ÒÇü Á¦¾à»çµµ ½±°Ô ÀÌ¿ëÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ¾ÈÁ¤¼ºÀ» À¯ÁöÇϱâ À§ÇØ °íµµÀÇ ÆÐŰ¡ ¼Ö·ç¼ÇÀ» ÇÊ¿ä·Î ÇÏ´Â »ý¹°ÇÐÀû Á¦Á¦ ¹× Ư¼ö ÀǾàǰÀ¸·ÎÀÇ Àüȯµµ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾ç ¹× ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ½ÅÈï ½ÃÀå¿¡¼­´Â ÀÇ·á ¼­ºñ½º Á¢±Ù¼º Çâ»ó, °¡Ã³ºÐ ¼Òµæ Áõ°¡, ÀÇ·á ÀÎÇÁ¶ó °­È­¸¦ À§ÇÑ Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºêÀÇ Áõ°¡·Î ÀÎÇØ ÀǾàǰ Æ÷Àå¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Á¤ºÎÀÇ ±ÔÁ¦¿Í ¼ÒºñÀÚÀÇ ÁöÁö¸¦ ¹ÙÅÁÀ¸·Î ÇÑ Áö¼Ó°¡´ÉÇÑ Æ÷Àå¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ÃßÁøÀ¸·Î ÀÎÇØ Á¦Á¶¾÷ü´Â ÀçȰ¿ë °¡´ÉÇÑ »ýºÐÇØ¼º ºí¸®½ºÅÍ ÆÑ¿¡ ÅõÀÚÇÒ ¼ö¹Û¿¡ ¾ø½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀÌ º¹ÇÕÀûÀ¸·Î ÀÛ¿ëÇÏ¿© ¼¼°è Á¤¼¼´Â Å©°Ô º¯È­Çϰí ÀÖÀ¸¸ç, º¸´Ù ¾ÈÀüÇϰí È¿À²ÀûÀ̸ç ȯ°æ ģȭÀûÀÎ ÀǾàǰ Æ÷ÀåÀ» ½ÇÇöÇϱâ À§ÇÑ ±â¼ú Çõ½Å, ±ÔÁ¦ Áؼö, ¼ÒºñÀÚ Áß½ÉÀÇ ¼Ö·ç¼ÇÀ» ÃßÁøÇϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

À¯Çü(Ä«µå, Ŭ·¥½©), Àç·á(Á¾ÀÌ¡¤ÆÇÁö, ÇÃ¶ó½ºÆ½ Çʸ§, ¾Ë·ç¹Ì´½), ±â¼ú(¿­¼ºÇü, ³Ã°£ ¼ºÇü), ¿ëµµ(Á¤Á¦, ĸ½¶, ºÐ¸», ÀÇ·á±â±â)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê

AI ÅëÇÕ

Global Industry Analysts´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM ¹× ¾÷°èº° SLM Äõ¸®¸¦ µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû, °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Healthcare Blister Packaging Market to Reach US$28.6 Billion by 2030

The global market for Healthcare Blister Packaging estimated at US$20.3 Billion in the year 2024, is expected to reach US$28.6 Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2024-2030. Carded Type, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$16.0 Billion by the end of the analysis period. Growth in the Clamshell Type segment is estimated at 7.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$5.5 Billion While China is Forecast to Grow at 9.1% CAGR

The Healthcare Blister Packaging market in the U.S. is estimated at US$5.5 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$5.7 Billion by the year 2030 trailing a CAGR of 9.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.0% and 5.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Healthcare Blister Packaging Market - Key Trends & Drivers Summarized

Why Is Blister Packaging Becoming the Gold Standard in Healthcare Packaging?

The healthcare blister packaging market is witnessing a rapid transformation, fueled by the evolving demands of pharmaceutical and medical industries. Blister packaging, a widely used protective packaging solution, is becoming the preferred choice due to its ability to ensure product integrity, improve patient compliance, and meet stringent regulatory standards. This shift is driven by the rising global pharmaceutical demand, an aging population requiring more medication, and the need for tamper-proof and child-resistant packaging solutions. The pharmaceutical sector has particularly embraced blister packaging because it offers superior protection against environmental factors such as moisture, oxygen, and light, which could compromise the efficacy of drugs. Additionally, single-dose packaging ensures accurate dosage and prevents contamination, enhancing safety for consumers. Moreover, the ability to integrate smart features, such as QR codes and near-field communication (NFC) tags, has revolutionized how patients access medication information, leading to better adherence to prescribed treatments. Sustainability has also become a key driver, with manufacturers increasingly incorporating recyclable and biodegradable materials to meet growing environmental concerns. Regulatory bodies such as the FDA and the European Medicines Agency (EMA) have mandated stringent guidelines that favor blister packaging over traditional bottles and vials, further propelling its adoption. Additionally, the cost-effectiveness of blister packaging in terms of production, storage, and transportation has reinforced its dominance in the market. The growing demand for over-the-counter (OTC) medicines and dietary supplements, coupled with the surge in self-medication trends, has also expanded the market scope. With these factors converging, blister packaging is emerging as the definitive solution for pharmaceutical packaging, offering unmatched protection, usability, and regulatory compliance.

What’s Fueling the Rise of Smart and Sustainable Blister Packaging?

Technological advancements in blister packaging have significantly shaped the industry, with innovations geared towards sustainability, convenience, and enhanced patient engagement. Smart packaging, which integrates digital solutions such as RFID, NFC, and Bluetooth-enabled features, is transforming how medications are managed, tracked, and consumed. These technologies help monitor medication adherence, allowing healthcare providers to track whether patients are taking their prescribed doses correctly. This is particularly beneficial in managing chronic diseases where strict medication schedules are necessary. Additionally, sustainable blister packaging is gaining traction, driven by the urgent need to reduce plastic waste and carbon footprints. Manufacturers are increasingly adopting recyclable, paper-based, and bio-based polymers that provide the same level of protection as traditional materials but with a reduced environmental impact. Advanced barrier films that minimize material usage while maintaining product safety are also gaining widespread adoption. The push for sustainability is not only regulatory-driven but also consumer-led, as end-users now demand eco-friendly solutions in all industries, including healthcare. Furthermore, continuous innovation in high-speed and precision-oriented blister packaging machinery has enhanced production efficiency, reducing costs while improving scalability for pharmaceutical manufacturers. The incorporation of laser engraving and digital printing in blister packaging has also allowed for enhanced branding, anti-counterfeiting measures, and personalized patient communication. These technological developments are positioning blister packaging as the future of healthcare packaging, integrating sustainability with enhanced functionality. The convergence of digital health trends and eco-conscious packaging solutions is set to redefine the competitive landscape, compelling manufacturers to invest in advanced technologies to stay ahead in this rapidly evolving market.

How Are Consumer Behavior and Regulations Shaping the Market?

Consumer preferences and stringent regulations are playing a pivotal role in shaping the healthcare blister packaging market. One of the most significant behavioral shifts is the increasing reliance on self-medication and over-the-counter drugs, particularly among aging populations and health-conscious consumers. Blister packaging facilitates this trend by providing pre-measured doses, easy-to-follow medication schedules, and tamper-evident features, ensuring patient safety. The COVID-19 pandemic further accelerated the shift towards self-medication and e-pharmacy channels, boosting the demand for blister-packed medications that are easy to ship and store. Additionally, the rise of pediatric and geriatric patient populations has created the need for packaging that is both child-resistant and senior-friendly, balancing security with accessibility. Regulatory frameworks worldwide are tightening their grip on pharmaceutical packaging, necessitating compliance with serialization, traceability, and child-resistant standards. The U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and other regulatory bodies mandate that blister packaging meets strict safety and traceability requirements to curb drug counterfeiting and ensure consumer protection. In Europe, the Falsified Medicines Directive (FMD) has mandated serialization for all prescription medicines, leading to increased integration of track-and-trace technologies within blister packs. Moreover, the demand for tamper-evident and security-enhanced packaging is growing in response to rising counterfeit drug incidents, which cost the pharmaceutical industry billions annually. With regulations evolving rapidly, pharmaceutical companies are compelled to adopt innovative blister packaging solutions that not only ensure compliance but also enhance consumer confidence. As a result, the market is seeing an uptick in demand for intelligent, easy-to-use, and compliance-friendly packaging solutions that align with the evolving preferences and safety requirements of global consumers.

What’s Driving the Explosive Growth of the Healthcare Blister Packaging Market?

The growth in the healthcare blister packaging market is driven by several factors, each significantly impacting the industry's trajectory. One of the primary drivers is the rapid expansion of the global pharmaceutical sector, fueled by increasing healthcare expenditure, the rise of chronic diseases, and the growing demand for personalized medicine. The need for secure and efficient drug delivery systems has made blister packaging the preferred choice for pharmaceutical companies looking to enhance patient safety while complying with evolving regulations. The surge in e-commerce and digital healthcare solutions has also contributed to the increased demand for protective, lightweight, and tamper-evident packaging that ensures medication integrity during shipping. Additionally, advancements in material science have enabled the development of high-barrier films, eco-friendly alternatives, and smart packaging solutions that cater to both regulatory demands and consumer preferences. The rising awareness of medication adherence has led to greater adoption of calendar-based and unit-dose blister packaging, especially for elderly and chronic disease patients. Furthermore, the expansion of contract manufacturing and packaging organizations (CMOs and CPOs) has facilitated cost-effective and scalable blister packaging solutions, making them more accessible to small and mid-sized pharmaceutical companies. The shift towards biologics and specialty drugs, which require sophisticated packaging solutions to maintain stability, is also accelerating market growth. Emerging markets in Asia-Pacific and Latin America are witnessing heightened demand for pharmaceutical packaging due to improved healthcare access, rising disposable incomes, and increasing government initiatives to enhance medical infrastructure. Additionally, the ongoing push for sustainable packaging, backed by government regulations and consumer advocacy, is forcing manufacturers to invest in recyclable and biodegradable blister packs. Collectively, these factors are reshaping the global healthcare blister packaging landscape, driving innovations, regulatory adherence, and consumer-focused solutions that ensure safer, more efficient, and environmentally responsible pharmaceutical packaging.

SCOPE OF STUDY:

The report analyzes the Healthcare Blister Packaging market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Carded Type, Clamshell Type); Material (Paper & Paperboard Material, Plastic Films Material, Aluminum Material); Technology (Thermoforming Technology, Cold Forming Technology); Application (Tablets Application, Capsules Application, Powders Application, Medical Devices Application)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 48 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â